NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ:RR).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Beyond Meat, Inc. ("Beyond Meat" or the "Company") (NASDAQ:BYND) and certain officers.�� The class action, filed in the United States District Court for the Central District of California, and docketed under
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE:BBWI).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO) and certain officers.�� The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803,
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Picard Medical, Inc. ("Picard" or the "Company") (NYSE:PMI).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against REGENXBIO Inc. ("Regenxbio" or the "Company") (NASDAQ:RGNX).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet Inc. ("Smartsheet" or the "Company") (NYSE:SMAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / February 22, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are